ArticleJournal of community health2026
Characterization of Nocturia and Urinary Voiding Indices Along the Heart Failure Continuum in US Male Veteran Patients.
Article in Journal of community health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart failure (HF) is a growing public health crisis that progresses from cardiovascular risk factors to structural/functional heart disease and eventual HF symptoms. Nocturia, long recognized as a HF symptom, has not been characterized along the HF continuum. To characterize nocturia across HF stages, we retrospectively analyzed voiding diaries and clinical data from US male veteran outpatients treated for lower urinary tract symptoms from 2008 to 2022. Patients were categorized into HF stages 0 (no risk factors), A (HF risk factors), B (stage A criteria + structural heart disease), and C (stage B criteria + prototypical HF signs/symptoms). Among 329 men, median actual void number (ANV) differed across HF stages (p = .011) and was maximal at Stage B. Among patients not taking diuretics - nocturnal voiding indices rose progressively through stage C, suggesting diuretic-mediated suppression of nocturia. There were trends toward higher nocturnal urine volume (NUV), nocturnal polyuria index (NPi) and nocturnal maximum voided volume (NMVV) in Stages B and C patient than Stage A. On multivariate analysis, HF stage was predictive of NUV and trended towards predicting ANV, whereas edema was an independent predictor of ANV, NUV, NPi, and NMVV. In a clinical urology population, nocturnal voiding indices were associated with HF stage, with the highest nocturia burden observed in Stage B (pre-HF) and independently with edema. Among men not taking diuretics, nocturia increased progressively through Stage C. These findings support nocturia as an early marker of volume overload that accompanies structural/functional heart disease, potentially preceding overt HF symptoms.
Indexed as
Identifiers
42801433What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.